Trials / Unknown
UnknownNCT03862599
Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy
Low Intensity Extracorporeal Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust · Academic / Other
- Sex
- Male
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. A few small studies have recently shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery.
Detailed description
Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. At present, this debilitating consequence of surgery is managed in a step-wise approach including oral medication, injections and in severe cases, insertion of a penile prosthesis. A few small studies have shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. The investigators propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery. Low-intensity shockwave therapy would be a non-invasive treatment to preserve and improve patient's sexual function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Extra-corporeal shockwave therapy (ESWT) | low-intensity extra-corporeal shockwave therapy |
| OTHER | Standard care | Cialis and vacuum pump |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2024-10-01
- Completion
- 2025-05-01
- First posted
- 2019-03-05
- Last updated
- 2023-03-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03862599. Inclusion in this directory is not an endorsement.